Testimonials
Collated independently by Legal 500 research team.
- ## INSERTED START: 26-01-2026 12:46:45
‘Accessibility and experience for IPO issuance is nearly unparalleled. The collaborative effort with banks and accessibility at all times of day / night supports seamless processes. ’
‘Tianwei Liu - despite being an associate, her transcation experience on IPOs provides a wealth of experience and makes tracking down answers easy. Its nice to not have a process delayed while the team has to look into things and she does a great job of often already knowing the answer / next steps. ’
‘Shearman has a very deep knowledge of the inner workings of an investment bank, policies, procedures and risk tolerances. This knowledge makes them uniquely suited to bank-side coverage. However these are able to pivot and represent issuers across multiple industry sectors with a particular strength in the biotech space.’
‘Deep capital markets expertise and experience on ECM side, incredibly responsive and very practical in terms of getting things done ’
Key clients
- ## INSERTED START: 11-12-2025 09:37:23
- Barclays
- BofA Securities
- Cohen & Company Capital Markets
- Consolidated Edison, Inc.
- DT Midstream, Inc.
- D. Boral Capital LLC
- Evercore ISI
- GMS Ventures & Investments
- Goldman Sachs & Co. LLC
- H.C. Wainwright & Co., LLC
- J.P. Morgan
Work highlights
Advised TD Securities and Goldman Sachs on a USD13.1bn secondary registered offering of shares of the Charles Schwab Corporation by the Toronto-Dominion Bank.
Advised the underwriters on the upsized USD202m initial public offering of Kestra Medical Technologies, Ltd.
Advised Consolidated Edison, Inc. on its forward sale agreement relating to the approximately USD677m forward sale of seven million of Con Edison’s common shares.